We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
13 hedge funds and large institutions have $2.37M invested in Interpace Biosciences, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
59% more capital invested
Capital invested by funds: $1.49M → $2.37M (+$879K)
24% less funds holding
Funds holding: 17 → 13 (-4)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$1.27M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$81.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$69.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$36.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$30.7K |
